During the progression of some cancers such as colorectal [53,54,95], tongue [53,54], and prostate cancer [67,91,96], changes in cellular localization (shuttling from the nucleus to the cytoplasm) of Gal3 have been observed. This evidence concerns the gene LGALS3 and prostate carcinoma.